scholarly article | Q13442814 |
P356 | DOI | 10.1039/C5OB01395J |
P698 | PubMed publication ID | 26338696 |
P50 | author | Minoru Ishikawa | Q59167430 |
Shusuke Tomoshige | Q86069835 | ||
P2093 | author name string | Yuichi Hashimoto | |
Mikihiko Naito | |||
P2860 | cites work | HaloTag: a novel protein labeling technology for cell imaging and protein analysis | Q42809086 |
Chemical control of protein stability and function in living mice. | Q43066313 | ||
Target-selective photo-degradation of verotoxin-1 and reduction of its cytotoxicity to Vero cells using porphyrin-globotriose hybrids. | Q44588733 | ||
Photodegradation and inhibition of drug-resistant influenza virus neuraminidase using anthraquinone-sialic acid hybrids. | Q45353233 | ||
HaloTag7: a genetically engineered tag that enhances bacterial expression of soluble proteins and improves protein purification | Q47739171 | ||
Light-Activated Proteolysis for the Spatiotemporal Control of Proteins. | Q50981422 | ||
Development and applications of CRISPR-Cas9 for genome engineering | Q28241526 | ||
Small molecules destabilize cIAP1 by activating auto-ubiquitylation | Q28266432 | ||
Molecular mechanisms of RNA interference | Q28290306 | ||
DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation | Q28830958 | ||
A plant-like kinase in Plasmodium falciparum regulates parasite egress from erythrocytes | Q30042180 | ||
Development of target protein-selective degradation inducer for protein knockdown. | Q33880402 | ||
Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation | Q34083015 | ||
Design, synthesis and biological evaluation of nuclear receptor-degradation inducers. | Q34225932 | ||
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4. | Q34478968 | ||
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. | Q34479551 | ||
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins | Q34480529 | ||
Catalytic in vivo protein knockdown by small-molecule PROTACs. | Q34480735 | ||
Pharmacological targeting of the pseudokinase Her3 | Q34514043 | ||
Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway | Q34662199 | ||
Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins. | Q35115865 | ||
Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs | Q36895558 | ||
Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets | Q37820063 | ||
Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system | Q38181445 | ||
Regulation of target protein knockdown and labeling using ligand-directed Ru(bpy)3 photocatalyst | Q38924509 | ||
Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist. | Q39338448 | ||
Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy. | Q39406339 | ||
Small-molecule displacement of a cryptic degron causes conditional protein degradation | Q39513760 | ||
Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein. | Q39574650 | ||
Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins. | Q39718603 | ||
An auxin-based degron system for the rapid depletion of proteins in nonplant cells. | Q39774277 | ||
Direct pH measurements by using subcellular targeting of 5(and 6-) carboxyseminaphthorhodafluor in mammalian cells | Q39784169 | ||
Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer | Q39939428 | ||
Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2. | Q40533310 | ||
Chemical genetic control of protein levels: selective in vivo targeted degradation | Q40574972 | ||
General method for regulating protein stability with light | Q41900311 | ||
A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules | Q42166429 | ||
Rapid control of protein level in the apicomplexan Toxoplasma gondii | Q42714117 | ||
P433 | issue | 38 | |
P304 | page(s) | 9746-9750 | |
P577 | publication date | 2015-10-01 | |
P1433 | published in | Organic and Biomolecular Chemistry | Q3355939 |
P1476 | title | Degradation of HaloTag-fused nuclear proteins using bestatin-HaloTag ligand hybrid molecules | |
P478 | volume | 13 |
Q59798588 | Chemically Induced Cellular Proteolysis: An Emerging Therapeutic Strategy for Undruggable Targets |
Q89823393 | Degradation of proteins by PROTACs and other strategies |
Q41247551 | Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands. |
Q45303178 | Discovery of Small Molecules that Induce the Degradation of Huntingtin |
Q34545841 | Induced protein degradation: an emerging drug discovery paradigm |
Q92758119 | PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future |
Q58756135 | Pharmacological difference between degrader and inhibitor against oncogenic BCR-ABL kinase |
Q89662693 | REX technologies for profiling and decoding the electrophile signaling axes mediated by Rosetta Stone proteins |
Q38978952 | Targeted Protein Degradation by Small Molecules |
Q96431675 | Targeted protein degradation as a powerful research tool in basic biology and drug target discovery |